News and Press Releases
Press releases
Theralase Submits Anti-Cancer Technology to Research Ethics Board for Approval
Toronto, Ontario – September 21, 2015, Theralase Technologies Inc. (“Theralase” or the “Company”) (TLT:TSXV) (TLTFF:OTC), a leading biote...
0Theralase Submits Investigational Testing Authorization to Health Canada for Approval
Toronto, Ontario – September 18, 2015, Theralase Technologies Inc. (“Theralase” or the “Company”) (TLT:TSXV) (TLTFF:OTC), a leading biote...
0Theralase Submits Clinical Trial Application to Health Canada for Approval
Toronto, Ontario – September 17, 2015, Theralase Technologies Inc. (“Theralase” or the “Company”) (TLT:TSXV) (TLTFF:OTC), a leading biote...
0Theralase Completes Detailed Information on the TLC-3000B Laser System
Toronto, Ontario – September 15, 2015, Theralase Technologies Inc. (“Theralase” or the “Company”) (TLT:TSXV) (TLTFF:OTC), a leading biote...
0Theralase Completes Clinical Protocol
Toronto, Ontario – September 11, 2015, Theralase Technologies Inc. (“Theralase” or the “Company”) (TLT:TSXV) (TLTFF:OTC), a leading biote...
0Theralase Successfully Completes GLP Toxicology Analysis of Lead Drug
Toronto, Ontario – September 10, 2015, Theralase Technologies Inc. (“Theralase” or the “Company”) (TLT:TSXV) (TLTFF:OTC), a leading biote...
0Theralase Research Demonstrates Lead Drug Also Effective for Muscle Invasive Bladder Cancer
Toronto, Ontario – September 9, 2015, Theralase Technologies Inc. (“Theralase” or the “Company”) (TLT:TSXV) (TLTFF:OTC), a leading biotec...
0Theralase Completes GMP Manufacture of Lead Drug
Toronto, Ontario – September 8, 2015, Theralase Technologies Inc. (“Theralase” or the “Company”) (TLT:TSXV) (TLTFF:OTC), a leading biotec...
0Theralase Demonstrates Stability of Lead Drug
Toronto, Ontario – September 4, 2015, Theralase Technologies Inc. (“Theralase” or the “Company”) (TLT:TSXV) (TLTFF:OTC), a leading biotec...
0Theralase Expands Photo Dynamic Compound Pipeline
Toronto, Ontario – September 3, 2015, Theralase Technologies Inc. (“Theralase” or the “Company”) (TLT:TSXV) (TLTFF:OTC), a leading biotec...
0in the news
Let's Stay in Touch
Sign up to our newsletter to stay informed on news and updates from Theralase Technologies Inc.
